Qili Qiangxin (QLQX) capsule as a multi-functional traditional Chinese medicine in treating chronic heart failure (CHF): A review of ingredients, molecular, cellular, and pharmacological mechanisms
Author:
Wang TongxingORCID, Hou Bin, Qin Haoran, Liang Junqing, Shi Min, Song Yanfei, Ma Kun, Chen Meng, Li Huixin, Ding Guoyuan, Yao Bing, Wang Zhixin, Wei Cong, Jia Zhenhua
Funder
National Key Research and Development Program of China Sichuan Provincial Administration of Traditional Chinese Medicine
Subject
Multidisciplinary
Reference229 articles.
1. The Lancet;Ma,2023 2. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015 3. T. Jasper, T. H. Teng, T. W. Ting, H. C. Lieh, N. Calambur, S. Wataru, P. S. Weon, L. H. Bang, N. Tachapong and E. B. Reyes, European Journal of Heart Failure, 2018. 4. C. S. Lam, T. K. Teng, W. T. Tay, I. Anand, S. Zhang, W. Shimizu, C. Narasimhan, S. W. Park, C. M. Yu, T. Ngarmukos, R. Omar, E. B. Reyes, B. B. Siswanto, C. L. Hung, L. H. Ling, J. Yap, M. MacDonald and A. M. Richards, Eur. Heart J., 2016, 37, 3141-3153.
|
|